Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Eyes China Community Hospital Market

This article was originally published in PharmAsia News

Executive Summary

China's health care reform which aims to maintain public health service is set to impact pharmaceutical MNCs. Foreign corporations are looking at community hospitals as a potential market, and Novartis has established a special institution that collaborates with community hospitals. The head of Novartis China believes local pharmaceutical companies will benefit more than MNCs from the reform, but the latter can still participate in basic health care with their generic drugs. China's immunity program expansion also brings business opportunities. Novartis is discussing with China National Biotec Group, China's key state vaccine manufacturer, on possible cooperation. (Click here for more - Chinese Language)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC067872

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel